Daily Science Fiction‘s featured story for today is “Kill Switch.” Check it out if you’re in the mood for a flash tale of biotechnology, professionalism, and evil.
I made my first sale to a pro market this week. I am incredibly pleased.
Obviously, money doesn’t equal quality, “pro rates” are still laughably low, etc., etc. But what I write is largely recognizable as belonging to commercial genres, and well-resourced publications attract talent. Making it to the second round of consideration in pro magazines I enjoy was a nice ego-boost last year. Clearing that final hurdle is an even bigger one.